We performed multivariate survival analysis for, in this material, previously independent prognostic factors (age, grade, stage, residual tumour size, and aberrant p53 immunoreactivity) (Lassus et al, 2003; Erkinheimo et al, 2004). This evidence concerns the gene TP53 and neoplasm.